MMSI Merit Medical Systems Inc.

Merit Medical Systems to Announce Second Quarter Results on July 29, 2020

Merit Medical Systems to Announce Second Quarter Results on July 29, 2020

SOUTH JORDAN, Utah, July 17, 2020 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology, oncology, critical care and endoscopy announced today that it will release its financial results for the quarter ended June 30, 2020, after the close of the stock market on Wednesday, July 29, 2020.

Merit will hold its investor conference call (conference ID6997109) on the same day (Wednesday, July 29, 2020) at 5:00 p.m. Eastern (4:00 p.m. Central, 3:00 p.m. Mountain, and 2:00 p.m. Pacific).  The telephone numbers to call are (domestic) (844) 578-9672; and (international) (508) 637-5656.  A live webcast will also be available for the conference call at .

ABOUT MERIT

Founded in 1987, Merit Medical Systems, Inc. is engaged in the development, manufacture and distribution of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy. Merit serves client hospitals worldwide with a domestic and international sales force and clinical support team totaling in excess of 300 individuals. Merit employs approximately 6,000 people worldwide with facilities in South Jordan, Utah; Pearland, Texas; Richmond, Virginia; Malvern, Pennsylvania; Rockland, Massachusetts; Aliso Viejo, California; Maastricht and Venlo, The Netherlands; Paris, France; Galway, Ireland; Beijing, China; Tijuana, Mexico; Joinville, Brazil; Markham, Ontario, Canada; Melbourne, Australia; Tokyo, Japan; Reading, United Kingdom; Johannesburg, South Africa; and Singapore.

CONTACTS:

Judy Wagner

Corporate Communications

(801) 208-4793 (office)



Patrick McCarty

Investor Relations

(801) 208-4581 (office)



EN
17/07/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Merit Medical Systems Inc.

 PRESS RELEASE

First Patient Enrolled in Merit Medical’s WRAPSODY (WRAP) North Americ...

First Patient Enrolled in Merit Medical’s WRAPSODY (WRAP) North America Registry The WRAP North America registry is a prospective, multicenter study designed to collect real-world safety and effectiveness data on the WRAPSODY® Cell-Impermeable Endoprosthesis (CIE).The first WRAP North America patient was enrolled at Bluff City Vascular, an interventional nephrology and vascular access center in Memphis, TN. SOUTH JORDAN, Utah, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced today the successful enroll...

 PRESS RELEASE

Merit Medical Launches the Prelude Wave Hydrophilic Sheath Introducer ...

Merit Medical Launches the Prelude Wave Hydrophilic Sheath Introducer with SnapFix Technology Thin-wall design with superior insertion and unique sheath-securement solution to support successful radial access procedures and may aid in reducing arterial spasm and occlusion SOUTH JORDAN, Utah, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced the US commercial release of the Prelude Wave™ Hydrophilic Sheath Introducer with SnapFix™ Securement Technology. The Prelude Wave is the latest innovation in Meri...

 PRESS RELEASE

Merit Medical Reports Second Quarter 2025 Results and Updates Full-Yea...

Merit Medical Reports Second Quarter 2025 Results and Updates Full-Year Guidance Highlights† Reported revenue of $382.5 million, up 13.2%Constant currency revenue* and constant currency revenue, organic* up 12.5% and up 6.7%, respectivelyGAAP operating margin of 12.3%, compared to 13.6% in prior year periodNon-GAAP operating margin* of 21.2%, compared to 20.1% in prior year periodGAAP EPS $0.54, down 11.6%Non-GAAP EPS* $1.01, up 9.8%Free cash flow* generation of $89.1 million over first six months of 2025, up 8.1% year-over-yearAcquired Biolife Delaware, L.L.C. (“Biolife”), a manufacturer ...

 PRESS RELEASE

Merit Medical Names Martha Aronson as New President and Chief Executiv...

Merit Medical Names Martha Aronson as New President and Chief Executive Officer Fred Lampropoulos will continue to serve as Chairman of Merit’s Board of Directors Merit announces preliminary unaudited revenue for the quarter ended June 30, 2025 SOUTH JORDAN, Utah, July 07, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced today the appointment of Martha Aronson as Merit’s new President and Chief Executive Officer, effective October 3, 2025. Fred P. Lampropoulos will remain as Chairman of the Board, President and CEO ...

 PRESS RELEASE

Merit Medical Systems To Announce Second Quarter 2025 Results On July ...

Merit Medical Systems To Announce Second Quarter 2025 Results On July 30, 2025 SOUTH JORDAN, Utah, July 03, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will release its financial results for the quarter ended June 30, 2025, after the close of the stock market on Wednesday, July 30, 2025. Merit plans to hold its investor conference call on the same day (Wednesday, July 30, 2025) at 5:00 p.m. Eastern (4:00 p.m. Central, 3:00 p.m. Mountain, and 2:00 p.m. Pacific). To access ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch